News

Acute myelogenous leukemia, or AML, remains one of the most aggressive blood cancers. Each year, around 44,000 people in the ...
Kura Oncology and Kyowa Kirin submitted data from the KOMET-001 trial, which the agency will review and decide whether to approve the drug by Nov. 30.
Using the COMPASS model, researchers project risk of cardiac late effects for survivors of pediatric ALL at age 50 years.
Adolescent and young adult (AYA) patients with acute lymphoblastic leukemia (ALL) face significant survival disparities and ...
The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for ziftomenib as a treatment for adult patients with relapsed or refractory (R/R) acute myeloid ...
The Houston Texans are no exception. Bleacher Report's Moe Moton published an article Saturday suggesting one move every team still needs to make during the 2025 offseason. With Houston adding depth ...
The Houston Texans added a lot of new faces to their receiving corps this offseason. They acquired Christian Kirk from division-rival Jacksonville, and drafted a pair of Iowa State pass-catchers in ...
For Shenderov, the disease in the spotlight is acute promyelocytic leukemia (APL), a rare subform of leukemia that affects the white blood cells. Only 800 Americans are diagnosed with it each year.
Acute promyelocytic leukemia (APL) is a rare and aggressive form of leukemia, a cancer that affects blood cells. It is caused by a genetic mutation where two genes, PML and RARA, mistakenly fuse ...
For instance, one type is called acute promyelocytic leukemia (APL), which occurs when genes from chromosomes 15 and 17 switch places, creating an abnormal gene. This gene prevents a type of white ...
Because this treatment uses very high doses of chemotherapy, it can cause serious complications like these: Acute promyelocytic leukemia (APL) is a subtype of AML that doctors treat a little ...
high-risk acute promyelocytic leukemia (APL), the phase III APOLLO trial showed. The 2-year cumulative incidence of relapse was also significantly lower with the study combination compared with ...